Search In this Thesis
   Search In this Thesis  
العنوان
Allergic bronchopulmonary aspergillosis in bronchial asthma /
المؤلف
Abd El-Rahman, Ashraf Abd El-Haseeb Mohammad.
هيئة الاعداد
باحث / Ashraf Abd El-Haseeb Mohammad Abd El-Rahman
مشرف / Mohamed El-Desoky Abou Shehata
مشرف / Magda Aly Hany El-Backry
مشرف / Fatma Abbas Auf
مشرف / Ahmad Yones El-Sayed Badawy
الموضوع
Pulmonary aspergillosis.
تاريخ النشر
2008.
عدد الصفحات
221 p. + (4) p. Appen. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الطب الرئوي والالتهاب الرئوى
تاريخ الإجازة
1/1/2008
مكان الإجازة
جامعة المنصورة - كلية الطب - Chest
الفهرس
Only 14 pages are availabe for public view

from 236

from 236

Abstract

Aim of work: The aim of the work is to assess Prevalence of ABPA in bronchial ‎asthma and The efficacy of HRCT in diagnosis of ABPA.‎ Patients and methods: This case control study was carried out in Thoracic ‎Medicine Department in Collaboration with Clinical Pathology and Radiology ‎Departments, Mansoura University Hospital during the period from January ‎‎2004 to August 2006. This study comprised 210 patients with bronchial asthma ‎including 83 males and 127 females with age raging from 21 to 66 years with ‎mean 43  5.0 years.‎ Results: Aspergillin skin test positivity was found in 22.86% (48 out of 210) of ‎cases of bronchial asthma (BA). The grades of severity of BA in Aspergillin skin ‎test +ve cases were higher than Aspergillin –ve cases (31.25% vs 16.6% for ‎severe persistent BA, 41.66% vs 40.12% for moderate persistent BA and 27.08% ‎vs 24.69% for mild persistent BA). ABPA was diagnosed in 3.81% of cases of ‎BA (8 out of 210) with 2.86% of the BA cases diagnosed as ABPA-CB (6 out of ‎‎210) and 0.96% of the BA cases were diagnosed as ABPA-S (2 out of 210). ‎While among Aspergillin skin test +ve cases, the prevalence of ABPA was 16.6% ‎‎(8 out of 48) with 12.5% of the cases as ABPA-CB (6 out of 48) and 4.2% as ‎ABPA-S (2 out of 48). The degree of severity of BA with ABPA was higher than ‎in BA without ABPA (87.5% vs 17.33% for severe persistent BA). Also, all ‎cases of ABPA-CB were severe persistent BA compared to 50% of cases of ‎ABPA-S. The degree of severity of BA (severe persistent BA) were significantly ‎higher than non severe persistent BA (mild and moderate) regarding total IgE, ‎eosinophils, systemic steroids and ABPA (431.1  303.1 vs 124  108.1, 6.0  ‎‎2.4 vs 4.6  1.7, 14 (100%) vs 17 (51.5%) 7 (46.7%) vs 1 (3%) respectively) (P = ‎‎0.002, 0.023, 0.001, 0.000 respectively). There were higher degree of positivity of ‎Aspergillin skin test +ve with ABPA vs Aspergillin skin test +ve without ABPA ‎‎(50% vs 0% for +3 degree and 50% vs 30% for +2 degree).‎ Conclusions: Aspergillin skin test positivity is high in patients with BA (22.86%) ‎and is associated with a higher prevalence of ABPA (16.6%). ABPA is not a rare ‎disease in BA, as it occurs in 3.8% of cases of BA (8 out of 210). ABPA can be ‎predicted in patients with BA especially if they have higher degree of Aspergillin ‎skin test positivity (+3 and +2).‎